{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:05:00Z","timestamp":1787169900727,"version":"build-2736575974"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To investigate the prevalence and presentation of polypoidal choroidal vasculopathy (PCV) in Nigerians.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A cross-sectional, multicenter, hospital-based, descriptive study. Data were collected prospectively between January and December 2018, from consecutive patients diagnosed to have a retina disease at the general outpatient and retinal clinics of four eye departments in Nigeria. All participants had visual acuity, refraction, intraocular pressure, anterior segment examination, and dilated fundus examination. Some patients had fundus fluorescein angiography, optical coherence tomography (OCT), and OCT angiography (OCTA). Systemic comorbidity was determined by medical history and systemic evaluation. Diagnosis of PCV was based on clinical findings, and in some patients using OCT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 8,614 patients were seen and 15 patients (18 eyes) were diagnosed to have PCV giving a yearly hospital-based prevalence of 0.17%. The mean age at presentation was 63.27 \u00b1 11.5 years (range 44\u201384 years). There were nine females (60%). The male: female ratio was 1.5:1. Twelve (66.7%) of the 18 eyes were blind, 16.7% had severe visual impairment while 11.1% had mild visual impairment. Seven eyes (38.9%) had vitreous hemorrhage. Of the 12 blind eyes, 50% had vitreous hemorrhage (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.463). Nine patients (60%) had systemic hypertensive as comorbidity (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.016).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>PCV is a cause of vision loss among Nigerians. Majority of the eyes were blind and 50% of blind eyes had vitreous hemorrhage. Since Indocyanine Green Angiography is the most appropriate imaging technology and is mostly unavailable in Nigeria, efforts should be made to address this need and improve the diagnostic accuracy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/njcp.njcp_682_20","type":"journal-article","created":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:57:43Z","timestamp":1692579463000},"page":"1321-1325","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Polypoidal Choroidal Vasculopathy Amongst Nigerians; A Multicenter Study"],"prefix":"10.4103","volume":"24","author":[{"given":"O","family":"Adenuga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ON","family":"Okonkwo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MM","family":"Udoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Ovienra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Ibanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Agweye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Nkanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Akanbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Oyekunle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20240907","doi-asserted-by":"crossref","first-page":"2515841419831152","DOI":"10.1177\/2515841419831152","article-title":"Polypoidal choroidal vasculopathy: A comprehensive clinical update","volume":"11","author":"Kumar","year":"2019","journal-title":"Ther Adv Ophthalmol"},{"key":"R2-10-20240907","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1038\/s41433-018-0168-2","article-title":"Clinical outcomes in Caucasian patients with polypoidal choroidal vasculopathy","volume":"32","author":"Agorogiannis","year":"2018","journal-title":"Eye"},{"key":"R3-10-20240907","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006982-199010010-00001","article-title":"Idiopathic polypoidal choroidal vasculopathy (IPCV)","volume":"10","author":"Yannuzzi","year":"1990","journal-title":"Retina"},{"key":"R4-10-20240907","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1001\/archopht.1997.01100150480005","article-title":"The expanding Clinical Spectrum of idiopathic polypoidal choroidal vasculopathy","volume":"115","author":"Yannuzi","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"R5-10-20240907","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/0002-9394(85)90682-8","article-title":"Multiple recurrent serosanguineous retinal pigment epithelial detachments in black women","volume":"100","author":"Stern","year":"1985","journal-title":"Am J Ophthalmol"},{"key":"R6-10-20240907","first-page":"110","article-title":"Posterior uveal bleeding syndrome","volume":"94","author":"Kleiner","year":"1984","journal-title":"Ophthalmol"},{"key":"R7-10-20240907","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1001\/archopht.121.10.1392","article-title":"Polypoidal choroidal vasculopathy: Incidence, demographic features, and clinical characteristics","volume":"121","author":"Sho","year":"2003","journal-title":"Arch Ophtalmol"},{"key":"R8-10-20240907","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0002-9394(02)01404-6","article-title":"Polypoidal choroidal vasculopathy: Natural history","volume":"133","author":"Uyama","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"R9-10-20240907","doi-asserted-by":"crossref","first-page":"896","DOI":"10.4103\/ijo.IJO_1136_17","article-title":"Polypoidal choroidal vasculopathy: Pearls in diagnosis and management","volume":"66","author":"Anantharaman","year":"2018","journal-title":"Indian J Ophthalmol"},{"key":"R10-10-20240907","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s40135-017-0137-0","article-title":"Polypoidal choroidal vasculopathy","volume":"5","author":"Kim","year":"2017","journal-title":"Curr Ophthalmol Rep"},{"key":"R11-10-20240907","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2147\/OPTH.S226494","article-title":"Profile, visual presentation and burden of retinal diseases seen in ophthalmic clinics in Sub-Saharan Africa","volume":"14","author":"Nkanga","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"R12-10-20240907","doi-asserted-by":"crossref","first-page":"4729","DOI":"10.1167\/iovs.08-2134","article-title":"Clinicopathologic findings in polypoidal choroidal vasculopathy","volume":"49","author":"Nakashizuka","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R13-10-20240907","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000355488","article-title":"Polypoidal choroidal vasculopathy: Clinical features and genetic predisposition","volume":"231","author":"Honda","year":"2014","journal-title":"Ophthalmologica"},{"key":"R14-10-20240907","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.18240\/ijo.2019.12.07","article-title":"Long-term observation of vitrectomy without subretinal hemorrhage management for massive vitreous hemorrhage secondary to polypoidal choroidal vasculopathy","volume":"12","author":"Li","year":"2019","journal-title":"Int J Ophthalmol"},{"key":"R16-10-20240907","doi-asserted-by":"crossref","first-page":"20029","DOI":"10.1364\/OE.18.020029","article-title":"Ultrahigh speed 1050nm swept source\/Fourier domain OCT retinal and anterior segment imaging at 100,000 to 400,000 axial scans per second","volume":"18","author":"Potsaid","year":"2010","journal-title":"Opt Express"},{"key":"R18-10-20240907","doi-asserted-by":"crossref","first-page":"e000083","DOI":"10.1136\/bmjophth-2017-000083","article-title":"Indications and outcomes of vitrectomy surgery in a series of 1000 black African eyes","volume":"4","author":"Okonkwo","year":"2019","journal-title":"BMJ Open Ophthalmology"},{"key":"R19-10-20240907","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.2147\/OPTH.S47511","article-title":"Pattern of presentation of idiopathic polypoidal choroidal vasculopathy in Ibadan, Sub-Saharan Africa","volume":"7","author":"Oluleye","year":"2013","journal-title":"Clin Ophthalmol"},{"key":"R20-10-20240907","first-page":"1005","article-title":"Clinical characteristics of 254 cases of polypoidal choroidal vasculopathy","volume":"28","author":"Tao","year":"2012","journal-title":"Chinese J Ocul Fundus Dis"},{"key":"R21-10-20240907","doi-asserted-by":"crossref","first-page":"399","DOI":"10.4103\/0301-4738.67052","article-title":"Clinical features, management and visual outcome of polypoidal choroidal vasculopathy in Indian patients","volume":"58","author":"Anantharaman","year":"2010","journal-title":"Indian J Ophthalmol"},{"key":"R22-10-20240907","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1136\/bjophthalmol-2016-310074","article-title":"Polypoidal Choroidal vasculopathy: A common type of neovascular age-related macular degeneration in Caucasians","volume":"101","author":"Yadav","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"R23-10-20240907","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ajo.2010.05.035","article-title":"Polypoidal choroidal vasculopathy masquerading as neovascular age-related macular degeneration refractory to ranibizumab","volume":"150","author":"Stangos","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"R24-10-20240907","first-page":"92","article-title":"Prevalence and systemic relevant factors of polypoidal choroidal vasculopathy in a general Japanese population: The Hisayama study","volume":"52","author":"Yasuda","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R25-10-20240907","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00006982-199515020-00003","article-title":"Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy","volume":"15","author":"Spaide","year":"1995","journal-title":"Retina"}],"container-title":["Nigerian Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_682_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:14:38Z","timestamp":1787166878000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_682_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/njcp.njcp_682_20","relation":{},"ISSN":["1119-3077"],"issn-type":[{"value":"1119-3077","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]}}}